Global DNA Medicine Based on DNA Modification Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global market for DNA Medicine Based on DNA Modification is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key DNA Medicine Based on DNA Modification players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global DNA Medicine Based on DNA Modification market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global DNA Medicine Based on DNA Modification market, with both quantitative and qualitative data, to help readers understand how the DNA Medicine Based on DNA Modification market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the DNA Medicine Based on DNA Modification market and forecasts the market size by Type (Viral and Non-viral,), by Application (Neurological Diseases, Cancer and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of DNA Medicine Based on DNA Modification, Research Methodology, etc.
Chapter 2: Executive Summary, global DNA Medicine Based on DNA Modification market size and CAGR, DNA Medicine Based on DNA Modification market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: DNA Medicine Based on DNA Modification revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global DNA Medicine Based on DNA Modification revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global DNA Medicine Based on DNA Modification market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc.
Chapter 14: Research Findings and Conclusion
Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global market for DNA Medicine Based on DNA Modification is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China DNA Medicine Based on DNA Modification market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key DNA Medicine Based on DNA Modification players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global DNA Medicine Based on DNA Modification market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global DNA Medicine Based on DNA Modification market, with both quantitative and qualitative data, to help readers understand how the DNA Medicine Based on DNA Modification market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the DNA Medicine Based on DNA Modification market and forecasts the market size by Type (Viral and Non-viral,), by Application (Neurological Diseases, Cancer and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Viral
- Non-viral
- Neurological Diseases
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
Chapter 1: Scope of DNA Medicine Based on DNA Modification, Research Methodology, etc.
Chapter 2: Executive Summary, global DNA Medicine Based on DNA Modification market size and CAGR, DNA Medicine Based on DNA Modification market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: DNA Medicine Based on DNA Modification revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global DNA Medicine Based on DNA Modification revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global DNA Medicine Based on DNA Modification market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global DNA Medicine Based on DNA Modification Market Size 2017-2028
2.1.2 DNA Medicine Based on DNA Modification Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 DNA Medicine Based on DNA Modification Segment by Type
2.2.1 Viral
2.2.2 Non-viral
2.3 DNA Medicine Based on DNA Modification Market Size by Type
2.3.1 DNA Medicine Based on DNA Modification Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
2.4 DNA Medicine Based on DNA Modification Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 DNA Medicine Based on DNA Modification Market Size by Application
2.5.1 DNA Medicine Based on DNA Modification Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
3 DNA MEDICINE BASED ON DNA MODIFICATION MARKET SIZE BY PLAYER
3.1 DNA Medicine Based on DNA Modification Market Size Market Share by Players
3.1.1 Global DNA Medicine Based on DNA Modification Revenue by Players (2020-2022)
3.1.2 Global DNA Medicine Based on DNA Modification Revenue Market Share by Players (2020-2022)
3.2 Global DNA Medicine Based on DNA Modification Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DNA MEDICINE BASED ON DNA MODIFICATION BY REGIONS
4.1 DNA Medicine Based on DNA Modification Market Size by Regions (2017-2022)
4.2 Americas DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
4.3 APAC DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
4.4 Europe DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
4.5 Middle East & Africa DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas DNA Medicine Based on DNA Modification Market Size by Country (2017-2022)
5.2 Americas DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
5.3 Americas DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DNA Medicine Based on DNA Modification Market Size by Region (2017-2022)
6.2 APAC DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
6.3 APAC DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe DNA Medicine Based on DNA Modification by Country (2017-2022)
7.2 Europe DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
7.3 Europe DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa DNA Medicine Based on DNA Modification by Region (2017-2022)
8.2 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
8.3 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DNA MEDICINE BASED ON DNA MODIFICATION MARKET FORECAST
10.1 Global DNA Medicine Based on DNA Modification Forecast by Regions (2023-2028)
10.1.1 Global DNA Medicine Based on DNA Modification Forecast by Regions (2023-2028)
10.1.2 Americas DNA Medicine Based on DNA Modification Forecast
10.1.3 APAC DNA Medicine Based on DNA Modification Forecast
10.1.4 Europe DNA Medicine Based on DNA Modification Forecast
10.1.5 Middle East & Africa DNA Medicine Based on DNA Modification Forecast
10.2 Americas DNA Medicine Based on DNA Modification Forecast by Country (2023-2028)
10.2.1 United States DNA Medicine Based on DNA Modification Market Forecast
10.2.2 Canada DNA Medicine Based on DNA Modification Market Forecast
10.2.3 Mexico DNA Medicine Based on DNA Modification Market Forecast
10.2.4 Brazil DNA Medicine Based on DNA Modification Market Forecast
10.3 APAC DNA Medicine Based on DNA Modification Forecast by Region (2023-2028)
10.3.1 China DNA Medicine Based on DNA Modification Market Forecast
10.3.2 Japan DNA Medicine Based on DNA Modification Market Forecast
10.3.3 Korea DNA Medicine Based on DNA Modification Market Forecast
10.3.4 Southeast Asia DNA Medicine Based on DNA Modification Market Forecast
10.3.5 India DNA Medicine Based on DNA Modification Market Forecast
10.3.6 Australia DNA Medicine Based on DNA Modification Market Forecast
10.4 Europe DNA Medicine Based on DNA Modification Forecast by Country (2023-2028)
10.4.1 Germany DNA Medicine Based on DNA Modification Market Forecast
10.4.2 France DNA Medicine Based on DNA Modification Market Forecast
10.4.3 UK DNA Medicine Based on DNA Modification Market Forecast
10.4.4 Italy DNA Medicine Based on DNA Modification Market Forecast
10.4.5 Russia DNA Medicine Based on DNA Modification Market Forecast
10.5 Middle East & Africa DNA Medicine Based on DNA Modification Forecast by Region (2023-2028)
10.5.1 Egypt DNA Medicine Based on DNA Modification Market Forecast
10.5.2 South Africa DNA Medicine Based on DNA Modification Market Forecast
10.5.3 Israel DNA Medicine Based on DNA Modification Market Forecast
10.5.4 Turkey DNA Medicine Based on DNA Modification Market Forecast
10.5.5 GCC Countries DNA Medicine Based on DNA Modification Market Forecast
10.6 Global DNA Medicine Based on DNA Modification Forecast by Type (2023-2028)
10.7 Global DNA Medicine Based on DNA Modification Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen DNA Medicine Based on DNA Modification Product Offered
11.1.3 Biogen DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis DNA Medicine Based on DNA Modification Product Offered
11.2.3 Novartis DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences DNA Medicine Based on DNA Modification Product Offered
11.3.3 Gilead Sciences DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics DNA Medicine Based on DNA Modification Product Offered
11.4.3 Sarepta Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Product Offered
11.5.3 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen DNA Medicine Based on DNA Modification Product Offered
11.6.3 Amgen DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics DNA Medicine Based on DNA Modification Product Offered
11.7.3 Spark Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics DNA Medicine Based on DNA Modification Product Offered
11.8.3 Akcea Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio DNA Medicine Based on DNA Modification Product Offered
11.9.3 bluebird bio DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech DNA Medicine Based on DNA Modification Product Offered
11.10.3 Sunway Biotech DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO DNA Medicine Based on DNA Modification Product Offered
11.11.3 SIBIONO DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes DNA Medicine Based on DNA Modification Product Offered
11.12.3 AnGes DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics DNA Medicine Based on DNA Modification Product Offered
11.13.3 Orchard Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute DNA Medicine Based on DNA Modification Product Offered
11.14.3 Human Stem Cells Institute DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global DNA Medicine Based on DNA Modification Market Size 2017-2028
2.1.2 DNA Medicine Based on DNA Modification Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 DNA Medicine Based on DNA Modification Segment by Type
2.2.1 Viral
2.2.2 Non-viral
2.3 DNA Medicine Based on DNA Modification Market Size by Type
2.3.1 DNA Medicine Based on DNA Modification Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
2.4 DNA Medicine Based on DNA Modification Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 DNA Medicine Based on DNA Modification Market Size by Application
2.5.1 DNA Medicine Based on DNA Modification Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
3 DNA MEDICINE BASED ON DNA MODIFICATION MARKET SIZE BY PLAYER
3.1 DNA Medicine Based on DNA Modification Market Size Market Share by Players
3.1.1 Global DNA Medicine Based on DNA Modification Revenue by Players (2020-2022)
3.1.2 Global DNA Medicine Based on DNA Modification Revenue Market Share by Players (2020-2022)
3.2 Global DNA Medicine Based on DNA Modification Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DNA MEDICINE BASED ON DNA MODIFICATION BY REGIONS
4.1 DNA Medicine Based on DNA Modification Market Size by Regions (2017-2022)
4.2 Americas DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
4.3 APAC DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
4.4 Europe DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
4.5 Middle East & Africa DNA Medicine Based on DNA Modification Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas DNA Medicine Based on DNA Modification Market Size by Country (2017-2022)
5.2 Americas DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
5.3 Americas DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DNA Medicine Based on DNA Modification Market Size by Region (2017-2022)
6.2 APAC DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
6.3 APAC DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe DNA Medicine Based on DNA Modification by Country (2017-2022)
7.2 Europe DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
7.3 Europe DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa DNA Medicine Based on DNA Modification by Region (2017-2022)
8.2 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Type (2017-2022)
8.3 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DNA MEDICINE BASED ON DNA MODIFICATION MARKET FORECAST
10.1 Global DNA Medicine Based on DNA Modification Forecast by Regions (2023-2028)
10.1.1 Global DNA Medicine Based on DNA Modification Forecast by Regions (2023-2028)
10.1.2 Americas DNA Medicine Based on DNA Modification Forecast
10.1.3 APAC DNA Medicine Based on DNA Modification Forecast
10.1.4 Europe DNA Medicine Based on DNA Modification Forecast
10.1.5 Middle East & Africa DNA Medicine Based on DNA Modification Forecast
10.2 Americas DNA Medicine Based on DNA Modification Forecast by Country (2023-2028)
10.2.1 United States DNA Medicine Based on DNA Modification Market Forecast
10.2.2 Canada DNA Medicine Based on DNA Modification Market Forecast
10.2.3 Mexico DNA Medicine Based on DNA Modification Market Forecast
10.2.4 Brazil DNA Medicine Based on DNA Modification Market Forecast
10.3 APAC DNA Medicine Based on DNA Modification Forecast by Region (2023-2028)
10.3.1 China DNA Medicine Based on DNA Modification Market Forecast
10.3.2 Japan DNA Medicine Based on DNA Modification Market Forecast
10.3.3 Korea DNA Medicine Based on DNA Modification Market Forecast
10.3.4 Southeast Asia DNA Medicine Based on DNA Modification Market Forecast
10.3.5 India DNA Medicine Based on DNA Modification Market Forecast
10.3.6 Australia DNA Medicine Based on DNA Modification Market Forecast
10.4 Europe DNA Medicine Based on DNA Modification Forecast by Country (2023-2028)
10.4.1 Germany DNA Medicine Based on DNA Modification Market Forecast
10.4.2 France DNA Medicine Based on DNA Modification Market Forecast
10.4.3 UK DNA Medicine Based on DNA Modification Market Forecast
10.4.4 Italy DNA Medicine Based on DNA Modification Market Forecast
10.4.5 Russia DNA Medicine Based on DNA Modification Market Forecast
10.5 Middle East & Africa DNA Medicine Based on DNA Modification Forecast by Region (2023-2028)
10.5.1 Egypt DNA Medicine Based on DNA Modification Market Forecast
10.5.2 South Africa DNA Medicine Based on DNA Modification Market Forecast
10.5.3 Israel DNA Medicine Based on DNA Modification Market Forecast
10.5.4 Turkey DNA Medicine Based on DNA Modification Market Forecast
10.5.5 GCC Countries DNA Medicine Based on DNA Modification Market Forecast
10.6 Global DNA Medicine Based on DNA Modification Forecast by Type (2023-2028)
10.7 Global DNA Medicine Based on DNA Modification Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen DNA Medicine Based on DNA Modification Product Offered
11.1.3 Biogen DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis DNA Medicine Based on DNA Modification Product Offered
11.2.3 Novartis DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences DNA Medicine Based on DNA Modification Product Offered
11.3.3 Gilead Sciences DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics DNA Medicine Based on DNA Modification Product Offered
11.4.3 Sarepta Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Product Offered
11.5.3 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen DNA Medicine Based on DNA Modification Product Offered
11.6.3 Amgen DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics DNA Medicine Based on DNA Modification Product Offered
11.7.3 Spark Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics DNA Medicine Based on DNA Modification Product Offered
11.8.3 Akcea Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio DNA Medicine Based on DNA Modification Product Offered
11.9.3 bluebird bio DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech DNA Medicine Based on DNA Modification Product Offered
11.10.3 Sunway Biotech DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO DNA Medicine Based on DNA Modification Product Offered
11.11.3 SIBIONO DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes DNA Medicine Based on DNA Modification Product Offered
11.12.3 AnGes DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics DNA Medicine Based on DNA Modification Product Offered
11.13.3 Orchard Therapeutics DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute DNA Medicine Based on DNA Modification Product Offered
11.14.3 Human Stem Cells Institute DNA Medicine Based on DNA Modification Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. DNA Medicine Based on DNA Modification Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Viral
Table 3. Major Players of Non-viral
Table 4. DNA Medicine Based on DNA Modification Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 7. DNA Medicine Based on DNA Modification Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 10. Global DNA Medicine Based on DNA Modification Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global DNA Medicine Based on DNA Modification Revenue Market Share by Player (2020-2022)
Table 12. DNA Medicine Based on DNA Modification Key Players Head office and Products Offered
Table 13. DNA Medicine Based on DNA Modification Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global DNA Medicine Based on DNA Modification Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global DNA Medicine Based on DNA Modification Market Size Market Share by Regions (2017-2022)
Table 18. Americas DNA Medicine Based on DNA Modification Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas DNA Medicine Based on DNA Modification Market Size Market Share by Country (2017-2022)
Table 20. Americas DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 22. Americas DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 24. APAC DNA Medicine Based on DNA Modification Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Region (2017-2022)
Table 26. APAC DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 28. APAC DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 30. Europe DNA Medicine Based on DNA Modification Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Country (2017-2022)
Table 32. Europe DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 34. Europe DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of DNA Medicine Based on DNA Modification
Table 43. Key Market Challenges & Risks of DNA Medicine Based on DNA Modification
Table 44. Key Industry Trends of DNA Medicine Based on DNA Modification
Table 45. Global DNA Medicine Based on DNA Modification Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global DNA Medicine Based on DNA Modification Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global DNA Medicine Based on DNA Modification Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global DNA Medicine Based on DNA Modification Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global DNA Medicine Based on DNA Modification Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global DNA Medicine Based on DNA Modification Market Size Market Share Forecast by Application (2023-2028)
Table 51. Biogen Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 52. Biogen DNA Medicine Based on DNA Modification Product Offered
Table 53. Biogen DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 57. Novartis DNA Medicine Based on DNA Modification Product Offered
Table 58. Novartis Main Business
Table 59. Novartis DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 62. Gilead Sciences DNA Medicine Based on DNA Modification Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 67. Sarepta Therapeutics DNA Medicine Based on DNA Modification Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 77. Amgen DNA Medicine Based on DNA Modification Product Offered
Table 78. Amgen Main Business
Table 79. Amgen DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 82. Spark Therapeutics DNA Medicine Based on DNA Modification Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 87. Akcea Therapeutics DNA Medicine Based on DNA Modification Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Akcea Therapeutics Latest Developments
Table 91. bluebird bio Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 92. bluebird bio DNA Medicine Based on DNA Modification Product Offered
Table 93. bluebird bio Main Business
Table 94. bluebird bio DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 97. Sunway Biotech DNA Medicine Based on DNA Modification Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 102. SIBIONO DNA Medicine Based on DNA Modification Product Offered
Table 103. SIBIONO DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 107. AnGes DNA Medicine Based on DNA Modification Product Offered
Table 108. AnGes Main Business
Table 109. AnGes DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 112. Orchard Therapeutics DNA Medicine Based on DNA Modification Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 117. Human Stem Cells Institute DNA Medicine Based on DNA Modification Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Human Stem Cells Institute Latest Developments
Table 1. DNA Medicine Based on DNA Modification Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Viral
Table 3. Major Players of Non-viral
Table 4. DNA Medicine Based on DNA Modification Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 7. DNA Medicine Based on DNA Modification Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 10. Global DNA Medicine Based on DNA Modification Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global DNA Medicine Based on DNA Modification Revenue Market Share by Player (2020-2022)
Table 12. DNA Medicine Based on DNA Modification Key Players Head office and Products Offered
Table 13. DNA Medicine Based on DNA Modification Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global DNA Medicine Based on DNA Modification Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global DNA Medicine Based on DNA Modification Market Size Market Share by Regions (2017-2022)
Table 18. Americas DNA Medicine Based on DNA Modification Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas DNA Medicine Based on DNA Modification Market Size Market Share by Country (2017-2022)
Table 20. Americas DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 22. Americas DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 24. APAC DNA Medicine Based on DNA Modification Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Region (2017-2022)
Table 26. APAC DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 28. APAC DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 30. Europe DNA Medicine Based on DNA Modification Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Country (2017-2022)
Table 32. Europe DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 34. Europe DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of DNA Medicine Based on DNA Modification
Table 43. Key Market Challenges & Risks of DNA Medicine Based on DNA Modification
Table 44. Key Industry Trends of DNA Medicine Based on DNA Modification
Table 45. Global DNA Medicine Based on DNA Modification Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global DNA Medicine Based on DNA Modification Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global DNA Medicine Based on DNA Modification Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global DNA Medicine Based on DNA Modification Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global DNA Medicine Based on DNA Modification Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global DNA Medicine Based on DNA Modification Market Size Market Share Forecast by Application (2023-2028)
Table 51. Biogen Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 52. Biogen DNA Medicine Based on DNA Modification Product Offered
Table 53. Biogen DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 57. Novartis DNA Medicine Based on DNA Modification Product Offered
Table 58. Novartis Main Business
Table 59. Novartis DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 62. Gilead Sciences DNA Medicine Based on DNA Modification Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 67. Sarepta Therapeutics DNA Medicine Based on DNA Modification Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 77. Amgen DNA Medicine Based on DNA Modification Product Offered
Table 78. Amgen Main Business
Table 79. Amgen DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 82. Spark Therapeutics DNA Medicine Based on DNA Modification Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 87. Akcea Therapeutics DNA Medicine Based on DNA Modification Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Akcea Therapeutics Latest Developments
Table 91. bluebird bio Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 92. bluebird bio DNA Medicine Based on DNA Modification Product Offered
Table 93. bluebird bio Main Business
Table 94. bluebird bio DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 97. Sunway Biotech DNA Medicine Based on DNA Modification Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 102. SIBIONO DNA Medicine Based on DNA Modification Product Offered
Table 103. SIBIONO DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 107. AnGes DNA Medicine Based on DNA Modification Product Offered
Table 108. AnGes Main Business
Table 109. AnGes DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 112. Orchard Therapeutics DNA Medicine Based on DNA Modification Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, DNA Medicine Based on DNA Modification Area Served and Its Competitors
Table 117. Human Stem Cells Institute DNA Medicine Based on DNA Modification Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute DNA Medicine Based on DNA Modification Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Human Stem Cells Institute Latest Developments
LIST OF FIGURES
Figure 1. DNA Medicine Based on DNA Modification Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global DNA Medicine Based on DNA Modification Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global DNA Medicine Based on DNA Modification Market Size Market Share by Type in 2021
Figure 7. DNA Medicine Based on DNA Modification in Neurological Diseases
Figure 8. Global DNA Medicine Based on DNA Modification Market: Neurological Diseases (2017-2022) & ($ Millions)
Figure 9. DNA Medicine Based on DNA Modification in Cancer
Figure 10. Global DNA Medicine Based on DNA Modification Market: Cancer (2017-2022) & ($ Millions)
Figure 11. DNA Medicine Based on DNA Modification in Other
Figure 12. Global DNA Medicine Based on DNA Modification Market: Other (2017-2022) & ($ Millions)
Figure 13. Global DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 14. Global DNA Medicine Based on DNA Modification Revenue Market Share by Player in 2021
Figure 15. Global DNA Medicine Based on DNA Modification Market Size Market Share by Regions (2017-2022)
Figure 16. Americas DNA Medicine Based on DNA Modification Market Size 2017-2022 ($ Millions)
Figure 17. APAC DNA Medicine Based on DNA Modification Market Size 2017-2022 ($ Millions)
Figure 18. Europe DNA Medicine Based on DNA Modification Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa DNA Medicine Based on DNA Modification Market Size 2017-2022 ($ Millions)
Figure 20. Americas DNA Medicine Based on DNA Modification Value Market Share by Country in 2021
Figure 21. Americas DNA Medicine Based on DNA Modification Consumption Market Share by Type in 2021
Figure 22. Americas DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 23. United States DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Region in 2021
Figure 28. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 29. China DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 33. India DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Country in 2021
Figure 36. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Type in 2021
Figure 37. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 38. Germany DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 39. France DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 46. Egypt DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 52. APAC DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 53. Europe DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 55. United States DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 56. Canada DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 57. Mexico DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 58. Brazil DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 59. China DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 60. Japan DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 61. Korea DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 63. India DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 64. Australia DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 65. Germany DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 66. France DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 67. UK DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 68. Italy DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 69. Russia DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 70. Spain DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 71. Egypt DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 72. South Africa DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 73. Israel DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 74. Turkey DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 1. DNA Medicine Based on DNA Modification Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global DNA Medicine Based on DNA Modification Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global DNA Medicine Based on DNA Modification Market Size Market Share by Type in 2021
Figure 7. DNA Medicine Based on DNA Modification in Neurological Diseases
Figure 8. Global DNA Medicine Based on DNA Modification Market: Neurological Diseases (2017-2022) & ($ Millions)
Figure 9. DNA Medicine Based on DNA Modification in Cancer
Figure 10. Global DNA Medicine Based on DNA Modification Market: Cancer (2017-2022) & ($ Millions)
Figure 11. DNA Medicine Based on DNA Modification in Other
Figure 12. Global DNA Medicine Based on DNA Modification Market: Other (2017-2022) & ($ Millions)
Figure 13. Global DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 14. Global DNA Medicine Based on DNA Modification Revenue Market Share by Player in 2021
Figure 15. Global DNA Medicine Based on DNA Modification Market Size Market Share by Regions (2017-2022)
Figure 16. Americas DNA Medicine Based on DNA Modification Market Size 2017-2022 ($ Millions)
Figure 17. APAC DNA Medicine Based on DNA Modification Market Size 2017-2022 ($ Millions)
Figure 18. Europe DNA Medicine Based on DNA Modification Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa DNA Medicine Based on DNA Modification Market Size 2017-2022 ($ Millions)
Figure 20. Americas DNA Medicine Based on DNA Modification Value Market Share by Country in 2021
Figure 21. Americas DNA Medicine Based on DNA Modification Consumption Market Share by Type in 2021
Figure 22. Americas DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 23. United States DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Region in 2021
Figure 28. APAC DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 29. China DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 33. India DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Country in 2021
Figure 36. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Type in 2021
Figure 37. Europe DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 38. Germany DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 39. France DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Market Share by Application in 2021
Figure 46. Egypt DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country DNA Medicine Based on DNA Modification Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 52. APAC DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 53. Europe DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 55. United States DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 56. Canada DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 57. Mexico DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 58. Brazil DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 59. China DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 60. Japan DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 61. Korea DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 63. India DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 64. Australia DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 65. Germany DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 66. France DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 67. UK DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 68. Italy DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 69. Russia DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 70. Spain DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 71. Egypt DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 72. South Africa DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 73. Israel DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 74. Turkey DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries DNA Medicine Based on DNA Modification Market Size 2023-2028 ($ Millions)
